CompanyTrack
Sign Up Log In
A

ASTRAZENECA UK LIMITED

Active Cambridge

Activities of head offices

10,459 employees Website
Life sciences and medical technology Activities of head offices
A

ASTRAZENECA UK LIMITED

Activities of head offices

Founded 26 Nov 1998 Active Cambridge, United Kingdom 10,459 employees astrazeneca.co.uk
Life sciences and medical technology Activities of head offices
Accounts Submitted 7 Aug 2025
Confirmation Statement Submitted 17 Nov 2025
Net assets £42578.00M £27346.00M 2024 year on year
Total assets £49258.00M £28041.00M 2024 year on year
Total Liabilities £6680.00M £695.00M 2024 year on year
Charges 5
4 outstanding 1 satisfied

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA United Kingdom

Office (Macclesfield)

Alderley Park, Alderley House, Park Estate, Macclesfield SK10 4TF

Telephone

0800 783 0033

Credit Report

Discover ASTRAZENECA UK LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£9.00M

Decreased by £4.00M (-31%)

Net Assets

£42578.00M

Increased by £27346.00M (+180%)

Total Liabilities

£6680.00M

Increased by £695.00M (+12%)

Turnover

£15120.00M

Increased by £717.00M (+5%)

Employees

10459

Increased by 402 (+4%)

Debt Ratio

14%

Decreased by 14 (-50%)
See 10 Year Full Financials

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

£17.5m awarded
Show:

Investors (0)

No investor information available

Officers

Officers

13 active 22 resigned
Status
Alexander De Giorgio-millerDirectorBritishEngland4927 Jun 2024Active
Aradhana SarinDirectorAmericanUnited States512 Aug 2021Active
Caterina BrindicciDirectorItalianEngland5027 Jun 2024Active
Christine StephensDirectorBritishEngland5427 Jun 2024Active
Elaine HarropDirectorBritishEngland5127 Jun 2024Active
Iain Alistair CollinsDirectorBritishUnited Kingdom5531 May 2017Active
Lutz JermutusDirectorBritishUnited Kingdom5410 Feb 2025Active
Matthew Shaun BowdenSecretaryUnknownUnknown—1 May 2025Active

Shareholders

Shareholders (2)

Astrazeneca Intermediate Holdings Limited
100.0%
8,430,992,44327 Nov 2024
Astrazeneca Plc
0.0%
510,00027 Nov 2024

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Astrazeneca Intermediate Holdings Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors
See All Controllers

Group Structure

Group Structure

ASTRAZENECA INTERMEDIATE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ASTRAZENECA PLC united kingdom
ASTRAZENECA UK LIMITED Current Company
ALDERLEY PARK VENTURES LIMITED united kingdom significant influence or control
ARCHIGEN BIOTECH LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent
ARROW THERAPEUTICS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ASTRAZENECA CHINA UK LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ASTRAZENECA DEATH IN SERVICE TRUSTEE LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ASTRAZENECA EMPLOYEE SHARE TRUST LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ASTRAZENECA FINANCE LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ASTRAZENECA INVESTMENTS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ASTRAZENECA JAPAN LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ASTRAZENECA NOMINEES LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ASTRAZENECA QUEST LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ASTRAZENECA SHARE TRUST LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ASTRAZENECA TREASURY LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
AYZEE 1 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
AYZEE 2 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
AYZEE 3 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
AYZEE 4 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
BRITISH PHARMA GROUP LIMITED united kingdom voting rights 25 to 50 percent
CENTUS BIOTHERAPEUTICS LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent, significant influence or control
EVINOVA LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
KUDOS PHARMACEUTICALS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
MEDIMMUNE U.K. LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
MERONEM GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
VAXEQUITY LTD. united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

Charges

Charges

4 outstanding 1 satisfied

Documents

Company Filings

DateCategoryDescriptionDocument
11 Dec 2025OfficersChange to director Lutz Jermutus on 2025-12-10View(2 pages)
17 Nov 2025Confirmation StatementConfirmation statement made on 2025-11-17 with no updatesView(3 pages)
7 Aug 2025AccountsAnnual accounts made up to 2024-12-31View(63 pages)
2 May 2025OfficersAppointment of Matthew Shaun Bowden as director on 2025-05-01View(2 pages)
1 May 2025OfficersTermination of Adrian Charles Noel Kemp as director on 2025-05-01View(1 page)
11 Dec 2025 Officers

Change to director Lutz Jermutus on 2025-12-10

View Document(2 pages)
17 Nov 2025 Confirmation Statement

Confirmation statement made on 2025-11-17 with no updates

View Document(3 pages)
7 Aug 2025 Accounts

Annual accounts made up to 2024-12-31

View Document(63 pages)
2 May 2025 Officers

Appointment of Matthew Shaun Bowden as director on 2025-05-01

View Document(2 pages)
1 May 2025 Officers

Termination of Adrian Charles Noel Kemp as director on 2025-05-01

View Document(1 page)

Recent Activity

Latest Activity

Change to director Lutz Jermutus on 2025-12-10

2 months ago on 11 Dec 2025

Confirmation statement made on 2025-11-17 with no updates

3 months ago on 17 Nov 2025

Annual accounts made up to 2024-12-31

6 months ago on 7 Aug 2025

Appointment of Matthew Shaun Bowden as director on 2025-05-01

9 months ago on 2 May 2025

Termination of Adrian Charles Noel Kemp as director on 2025-05-01

9 months ago on 1 May 2025